FUJIFILM Diosynth Biotechnologies Welcomes UK Prime Minister Boris Johnson to UK COVID-19 Vaccine Manufacturing Site
BILLINGHAM, England, Feb. 13, 2021 /PRNewswire/ FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, viral vaccines and viral vectors, welcomed UK Prime Minister Boris Johnson to Teesside at its Billingham site, on Saturday 13 February to meet the team working to support the manufacture of a COVID-19 vaccine candidate.
During the visit, the Prime Minister toured the FUJIFILM Diosynth Biotechnologies facilities where the antigen component (active ingredient) of Novavax NVX-CoV2373 COVID-19 vaccine will be manufactured as well as other life-impacting therapies. Fujifilm s leading technical expertise in baculovirus systems and biopharmaceutical manufacturing excellence is contracted by Novavax to produce antigen for up to 180 million vaccine doses.